Ad is loading...
GCCAX
Price
$19.63
Change
-$0.39 (-1.95%)
Updated
Nov 15 closing price
RSLCX
Price
$63.97
Change
-$0.79 (-1.22%)
Updated
Nov 15 closing price
Ad is loading...

GCCAX vs RSLCX

Header iconGCCAX vs RSLCX Comparison
Open Charts GCCAX vs RSLCXBanner chart's image
GMO Climate Change R6
Price$19.63
Change-$0.39 (-1.95%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World R3
Price$63.97
Change-$0.79 (-1.22%)
VolumeN/A
CapitalizationN/A
GCCAX vs RSLCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GCCAX vs. RSLCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCCAX is a StrongBuy and RSLCX is a Buy.

FUNDAMENTALS
Fundamentals
RSLCX has more cash in the bank: 74.7B vs. GCCAX (662M). GCCAX pays higher dividends than RSLCX: GCCAX (1.01) vs RSLCX (0.45). GCCAX was incepted earlier than RSLCX: GCCAX (5 years) vs RSLCX (22 years). GCCAX is a more actively managed with annual turnover of: 57.00 vs. RSLCX (29.00). GCCAX has a lower initial minimum investment than RSLCX: GCCAX (0) vs RSLCX (250). RSLCX annual gain was more profitable for investors over the last year : 15.64 vs. GCCAX (-8.17).
GCCAXRSLCXGCCAX / RSLCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years22 years-
Gain YTD-20.5583.478-591%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets662M74.7B1%
Annual Yield % from dividends1.010.45225%
Returns for 1 year-8.1715.64-52%
Returns for 3 years-45.50-26.91169%
Returns for 5 yearsN/A16.21-
Returns for 10 yearsN/A33.00-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAM55.77-0.30
-0.54%
Brookfield Asset Management Ltd
CLB19.53-0.42
-2.11%
Core Laboratories
COSM0.63-0.02
-3.58%
Cosmos Health
VOXX6.49-0.31
-4.56%
VOXX International Corp
MLTX48.83-3.67
-6.99%
MoonLake Immunotherapeutics